Post-stroke dementia (PSD) or post-stroke cognitive impairment (PSCI) may affect up to one
third of stroke survivors. Various definitions of PSCI and PSD have been described. We …

Background Tenecteplase is a newer thrombolytic agent with some pharmacological advantages
over alteplase. Previous phase 2 trials of tenecteplase in acute ischaemic stroke have …

The TOAST classification divides patients with ischemic stroke into five subgroups according
to the presumed etiological mechanism. The aims of the present study were to evaluate the …

Background: Post-stroke dementia is defined as any dementia occurring after stroke, and
includes vascular, degenerative and mixed dementia. The aim of this study was to assess the …

Background Motor and cognitive impairments are frequently observed following stroke, but
are often managed as distinct entities, and there is little evidence regarding how they are …

Background: Post-stroke cognitive impairment (PSCI) is common, but evidence of cognitive
symptom profiles, course over time, and pathogenesis is scarce. We investigated the …

Objectives Vascular risk factor control may not only prevent stroke but also reduce the risk of
dementia. We investigated whether a multifactorial intervention program reduces the …

Background and Purpose— The evidence for interventions to prevent functional decline in the
long term after stroke is lacking. The aim of this trial was to evaluate the efficacy and safety …

Cognitive deficits are important predictors for outcome, independence and quality of life after
stroke, but often remain unnoticed and unattended because other impairments are more …

Introduction Post‐stroke neurocognitive disorder (NCD) is common; prevalence varies
between studies, partially related to lack of consensus on how to identify cases. The aim was to …